Noriko Nakura

Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction

S. Ito, D. Keefe, S. Breton, 2010, Hypertension Research.

Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.

K. Matsushita, H. Yotsuyanagi, H. Fukase, 2012, Vaccine.

Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children

K. Matsushita, M. Lattanzi, R. Komatsu, 2010, Advances in therapy.